Literature DB >> 36180688

Alternative Ligands at Melatonin Receptors.

Céline Legros1,2, Said Yous3, Jean A Boutin4,5.   

Abstract

Melatonin (N-acetyl-5-methoxytryptamine) is a neurohormone that possesses a wide range of biological effects. Most of the main recognized effects of this hormone in mammals are due to its interaction with two G protein-coupled receptors, MT1 and MT2. Ligand-binding studies have been based on the use of its radioligand analog, 2[125I]-iodomelatonin, a super agonist discovered in the early 1990s. This compound has been used in most of the binding studies reported in the literature. Nevertheless, more recently other possibilities arose. This chapter is a brief summary of those alternative radioligands and of their benefits one can find in using them.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Binding; Iodinated radioligand; Iodination; Melatonin; Radioligands; Tritiated ligand

Mesh:

Substances:

Year:  2022        PMID: 36180688     DOI: 10.1007/978-1-0716-2593-4_19

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  28 in total

1.  Characterization of central melatonin receptors using 125I-melatonin.

Authors:  M Laudon; N Zisapel
Journal:  FEBS Lett       Date:  1986-03-03       Impact factor: 4.124

2.  Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis.

Authors:  April Slee; Irwin Nazareth; Paulina Bondaronek; Yifeng Liu; Zhihang Cheng; Nick Freemantle
Journal:  Lancet       Date:  2019-01-31       Impact factor: 79.321

3.  Effects of ramelteon on insomnia symptoms induced by rapid, eastward travel.

Authors:  Phyllis C Zee; Sherry Wang-Weigand; Kenneth P Wright; Xuejun Peng; Thomas Roth
Journal:  Sleep Med       Date:  2010-05-18       Impact factor: 3.492

4.  Characterization of 2-[125I]iodomelatonin binding sites in hamster brain.

Authors:  M J Duncan; J S Takahashi; M L Dubocovich
Journal:  Eur J Pharmacol       Date:  1986-12-16       Impact factor: 4.432

5.  Pineal gland: dibutyryl cyclic adenosine monophosphate stimulation of labeled melatonin production.

Authors:  D C Klein; G R Berg; J Weller; W Glinsmann
Journal:  Science       Date:  1970-03-27       Impact factor: 47.728

6.  Pharmacological characterization of human recombinant melatonin mt(1) and MT(2) receptors.

Authors:  C Browning; I Beresford; N Fraser; H Giles
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

7.  Iodinated melatonin: preparation and characterization of the molecular structure by mass and 1H NMR spectroscopy.

Authors:  O Vakkuri; E Lämsä; E Rahkamaa; H Ruotsalainen; J Leppäluoto
Journal:  Anal Biochem       Date:  1984-11-01       Impact factor: 3.365

Review 8.  Melatonin receptor ligands: A pharmaco-chemical perspective.

Authors:  Jean A Boutin; Paula A Witt-Enderby; Christoph Sotriffer; Darius P Zlotos
Journal:  J Pineal Res       Date:  2020-07-05       Impact factor: 13.007

Review 9.  Is There Sufficient Evidence that the Melatonin Binding Site MT3 Is Quinone Reductase 2?

Authors:  Jean A Boutin; Gilles Ferry
Journal:  J Pharmacol Exp Ther       Date:  2018-11-02       Impact factor: 4.030

Review 10.  Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.

Authors:  Andrea Cipriani; Toshi A Furukawa; Georgia Salanti; Anna Chaimani; Lauren Z Atkinson; Yusuke Ogawa; Stefan Leucht; Henricus G Ruhe; Erick H Turner; Julian P T Higgins; Matthias Egger; Nozomi Takeshima; Yu Hayasaka; Hissei Imai; Kiyomi Shinohara; Aran Tajika; John P A Ioannidis; John R Geddes
Journal:  Lancet       Date:  2018-02-21       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.